Showing 1 - 20 results of 21 for search 'Andrew E Simor', query time: 0.06s Refine Results
  1. 1
    Bacteremia due to Helicobacter cinaedi in Two Patients with Human Immunodeficinecy Virus Infection

    Bacteremia due to Helicobacter cinaedi in Two Patients with Human Immunodeficinecy Virus Infection by Andrew E Simor, James L Brunton

    Published 1992-01-01
    Get full text
    Article
  2. 2
    Combined Topical and Oral Antimicrobial Therapy for the Eradication of Methicillin-Resistant Staphylococcus aureus (Mrsa) Colonization in Hospitalized Patients

    Combined Topical and Oral Antimicrobial Therapy for the Eradication of Methicillin-Resistant Staphylococcus aureus (Mrsa) Colonization in Hospitalized Patients by Scott K Fung, Marie Louie, Andrew E Simor

    Published 2002-01-01
    Get full text
    Article
  3. 3
    Positive Urine Cultures: A Major Cause of Inappropriate Antimicrobial Use in Hospitals?

    Positive Urine Cultures: A Major Cause of Inappropriate Antimicrobial Use in Hospitals? by Samuel A Silver, Laura Baillie, Andrew E Simor

    Published 2009-01-01
    Get full text
    Article
  4. 4
    The Isolation Rate of Escherichia coli 0157:H7 in Toronto and Surrounding Communities

    The Isolation Rate of Escherichia coli 0157:H7 in Toronto and Surrounding Communities by Andrew E Simor, Christine Watt, Donald E Low

    Published 1990-01-01
    Get full text
    Article
  5. 5
    Patient Characteristics and Outcomes of Outpatient Parenteral Antimicrobial Therapy: A Retrospective Study

    Patient Characteristics and Outcomes of Outpatient Parenteral Antimicrobial Therapy: A Retrospective Study by Marie Yan, Marion Elligsen, Andrew E. Simor, Nick Daneman

    Published 2016-01-01
    Get full text
    Article
  6. 6
    The Management of Infection and Colonization due to Methicillin-Resistant Staphylococcus aureus: A CIDS/CAMM Position Paper

    The Management of Infection and Colonization due to Methicillin-Resistant Staphylococcus aureus: A CIDS/CAMM Position Paper by Andrew E Simor, Mark Loeb, the CIDS/CAMM Guidelines Committee

    Published 2004-01-01
    Get full text
    Article
  7. 7
    Microbiologic Surveillance and Parenteral Antibiotic Use in a Critical Care Unit

    Microbiologic Surveillance and Parenteral Antibiotic Use in a Critical Care Unit by Sharon K Yamashita, Marie Louie, Andrew E Simor, Anita Rachlis

    Published 2000-01-01
    Get full text
    Article
  8. 8
    Emergence of Penicillin-Resistant Streptococcus Pneumoniae in Southern Ontario, 1993–94

    Emergence of Penicillin-Resistant Streptococcus Pneumoniae in Southern Ontario, 1993–94 by Andrew E Simor, Anita Rachlis, Lisa Louie, Janet Goodfellow, Marie Louie

    Published 1995-01-01
    Get full text
    Article
  9. 9
    Survey of Neisseria gonorrhoeae Antimicrobial Susceptibility in Ontario

    Survey of Neisseria gonorrhoeae Antimicrobial Susceptibility in Ontario by Vivian G Loo, Andrew E Simor, Ruth Jaeger, Donald E Low

    Published 1990-01-01
    Get full text
    Article
  10. 10
    A Caenorhabditis elegans Host Model Correlates with Invasive Disease Caused by Staphylococcus aureus Recovered during an Outbreak in Neonatal Intensive Care

    A Caenorhabditis elegans Host Model Correlates with Invasive Disease Caused by Staphylococcus aureus Recovered during an Outbreak in Neonatal Intensive Care by Kaiyu Wu, Andrew E Simor, Mary Vearncombe, Jo-Ann McClure, Kunyan Zhang

    Published 2012-01-01
    Get full text
    Article
  11. 11
    Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse Effects

    Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse Effects by George G Zhanel, Andrew E Simor, Lavern Vercaigne, Lionell Mandell, the Canadian Carbapenem Discussion Group

    Published 1998-01-01
    Get full text
    Article
  12. 12
    Comparative Evaluation of Seven Commercial Tests for Detection of Heterophile Antibody in Infectious Mononucleosis

    Comparative Evaluation of Seven Commercial Tests for Detection of Heterophile Antibody in Infectious Mononucleosis by Martin Skulnick, Donald E Low, Andrew E Simor, Mohan Patel, Pauline George, Robert Chua

    Published 1992-01-01
    Get full text
    Article
  13. 13
    Cross-Canada Survey of Resistance of 2747 Aerobic Blood Culture Isolates to Piperacillin/Tazobactam and Other Antibiotics

    Cross-Canada Survey of Resistance of 2747 Aerobic Blood Culture Isolates to Piperacillin/Tazobactam and Other Antibiotics by Kevin R Forward, Patricia A Franks, Donald E Low, Robert Rennie, Andrew E Simor, the Canadian Piperacillin/Tazobactam Study Group

    Published 1998-01-01
    Get full text
    Article
  14. 14
    Cotrimoxazole-Resistant Escherichia coli Bacteremia in Neutropenic Patients at a Regional Oncology Hospital

    Cotrimoxazole-Resistant Escherichia coli Bacteremia in Neutropenic Patients at a Regional Oncology Hospital by Daniel B Gregson, Anne G Matlow, Andrew E Simor, Peter G Tuffnell, Donald E Low, Ronald Feld, James E Brunton

    Published 1992-01-01
    Get full text
    Article
  15. 15
    Nursing Home Residents and Enterobacteriaceae Resistant to Third-Generation Cephalosporins

    Nursing Home Residents and Enterobacteriaceae Resistant to Third-Generation Cephalosporins by Carolyn Sandoval, Stephen D. Walter, Allison McGeer, Andrew E. Simor, Suzanne F. Bradley, Lorraine M. Moss, Mark B. Loeb

    Published 2004-06-01
    Get full text
    Article
  16. 16
    Comparative Antifungal Activity of Cilofungin (LY121019) against Candida Species, Including Evaluation of Susceptibility Testing Method

    Comparative Antifungal Activity of Cilofungin (LY121019) against Candida Species, Including Evaluation of Susceptibility Testing Method by Abdul H Chagla, John H Hii, Daryl J Hoban, Andrew E Simor, Santiago Ferro, Evelyn Witwicki, Ruby Poon, Donald E Low

    Published 1992-01-01
    Get full text
    Article
  17. 17
    Study of the Comparative Activity of Piperacillin/Tazobactam with Currently Available Antibiotics against 8206 Aerobic Isolates

    Study of the Comparative Activity of Piperacillin/Tazobactam with Currently Available Antibiotics against 8206 Aerobic Isolates by Kevin R Forward, Donald E Low, Michel Laverdiere, Robert Rennie, Andrew E Simor, Patricia A Franks, Members of the Canadian Piperacillin/Tazobactam Study Group

    Published 1997-01-01
    Get full text
    Article
  18. 18
    Diagnostic accuracy of subjective dyspnoea in detecting hypoxaemia among outpatients with COVID-19: a retrospective cohort study

    Diagnostic accuracy of subjective dyspnoea in detecting hypoxaemia among outpatients with COVID-19: a retrospective cohort study by Nick Daneman, Nisha Andany, Jerome A Leis, Linor Berezin, Alice Zhabokritsky, Adrienne K Chan, Jose Estrada-Codecido, Andrea Gershon, Philip W Lam, Scott MacPhee, Andrew E Simor

    Published 2021-03-01
    Get full text
    Article
  19. 19
    SARS in Healthcare Facilities, Toronto and Taiwan

    SARS in Healthcare Facilities, Toronto and Taiwan by L. Clifford McDonald, Andrew E. Simor, Ih-Jen Su, Susan Maloney, Marianna Ofner, Kow-Tong Chen, James F. Lando, Allison McGeer, Min-Ling Lee, Daniel B. Jernigan

    Published 2004-05-01
    Get full text
    Article
  20. 20
    Characterization of Methicillin-Resistant Staphylococcus aureus Isolates from Patients with Persistent or Recurrent Bacteremia

    Characterization of Methicillin-Resistant Staphylococcus aureus Isolates from Patients with Persistent or Recurrent Bacteremia by Henry Wong, Christine Watt, Sameer Elsayed, Michael John, Glen Johnson, Kevin Katz, Sigmund Krajden, Christine Lee, Tony Mazzulli, Krystyna Ostrowska, David Richardson, Baldwin Toye, Christie Vermeiren, Deborah Yamamura, Andrew E Simor

    Published 2014-01-01
    Get full text
    Article

Search Tools: